Executive Session

Open Executive Session to Consider an Original Bill Entitled The Prescription Drug Pricing Reduction Act of 2019

Date: 
Time: 
Location:  215 Dirksen Senate Office Building

Meeting Agenda

Member Statements

  1. Chuck Grassley

    R - IA
  2. Ron Wyden

    D - OR

Related Files

  1. Description of the Chairman's Mark for the Prescription Drug Pricing Reduction Act of 2019

  2. Amendments to the Chairman's Mark for the Prescription Drug Pricing Reduction Act of 2019

  3. Amendment List for the Prescription Drug Pricing Reduction Act of 2019

  4. Preliminary Estimate of the Original Bill Entitled the Prescription Drug Pricing Reduction Act of 2019

  5. Other Effects of Part D Redesign and Inflation-rebate Provisions

  6. Modifications to the Chairman's Mark of The Prescription Drug Pricing Reduction Act of 2019

  7. Results of Committee on Finance Open Executive Session on July 25, 2019

  8. Open Executive Session to Consider an Original Bill Entitled The Prescription Drug Pricing Reduction Act of 2019

Print 
Email 
Share 
Share 

How do I submit a statement for the record?

Any individual or organization wanting to present their views for inclusion in the hearing record should submit in a Word document, a single-spaced statement, not exceeding 10 pages in length. No other file type will be accepted for inclusion. Title and date of the hearing, and the full name and address of the individual or organization must appear on the first page of the statement. Statements must be received no later than two weeks following the conclusion of the hearing. Non-compliant submissions will not be accepted. Submissions are not reviewed by policy staff.

Statements can be emailed to:

Statementsfortherecord@finance.senate.gov

Statements can be mailed (not faxed) to:

Senate Committee on Finance
Attn. Editorial and Document Section
Rm. SD-219
Dirksen Senate Office Bldg.
Washington, DC 20510-6200